
The peptide industry is exploding in telemedicine and wellness, but is it safe, legal, and compliant? Hosts Phoebe Gutierrez and Leo Damasco dive into the "gray" world of peptides, from RFK Jr.'s recent push to reclassify many from FDA Category 2 to Category 1, to black-market risks, shady sourcing, and why not all peptides are created equal. They discuss enforcement crackdowns, questionable telehealth practices, and why due diligence matters for providers and patients chasing anti-aging, recovery, and performance benefits.
Loading summary